Early and Midterm Outcomes of Rheumatic Mitral Valve Repair
Background: Rheumatic heart disease (RHD) is the leading cause of mitral valve disease in the developing world. In general, mitral valve repair is preferred over replacement. Although it is very successful in degenerative disease, its results in the rheumatic valve are not as successful as that for degenerative repair. Our approach has been to repair rheumatic mitral valves when the anatomic substrate appears to permit it, and we aimed by this study to present our immediate and midterm follow-ups of our cohort of rheumatic valve repair patients.
Methods: From February 2011 to March 2013, 52 consecutive patients underwent mitral valve repair for rheumatic disease with different surgical techniques at the National Heart Institute of Egypt. Patients who had concomitant aortic or coronary artery bypass surgery were excluded. Also, patients needing an emergency operation or redo ones were excluded. On the contrary, patients who had concomitant tricuspid valve surgery were included. Demographic, intraoperative, and perioperative outcome data were recorded prospectively. All patients underwent TTE before hospital discharge. During follow-up, patients were contacted by telephone and invited for follow-up TTE yearly after their operations.
Results: Fifty-two patients with rheumatic disease underwent mitral repair. Their mean age was 25.92 ± 9.81 years. The study population was 78.8% female. Forty-nine patients were in New York Heart Association functional class III or IV. Repair procedures included implantation of Carpentier-Edwards
Classic mitral annuloplasty ring (100% of the whole study group). Mitral commissurotomy and repair of the subvalvular apparatus were generally performed. Thirteen neochordae were implanted. Anterior leaflet extension with an autologous pericardial patch was used in 4 patients; annular decalcification, in
2 patients; tricuspid repair with De Vega technique, in 18 patients (34.5%); and repair with Carpentier-Edwards Classic tricuspid annuloplasty ring, in 9 (17.3%) patients. There was no operative mortality. The mean follow-up time was 59.9 ± 5 postoperative months (range, 49-60 months). Only 2 patients (3.8%) died. Follow-up echocardiography revealed more-than-or-equal-to-moderate (2+) grade of MR in 5 patients. During the follow-up period, the mean LV end-diastolic diameter decreased significantly from 5.57 ± 1.06 cm to 4.93 ± 0.74 cm (<0.001). The mean pulmonary artery pressure decreased from 44.94 ± 17.01 mmHg to 35.69 ± 7.92 mmHg postoperatively (P < .001). The mean mitral valve area increased from 1.2 ± 0.9 cm2 to 2.3 ±
0.2 cm2 postoperatively (P < .001). The mean mitral valve gradient decreased significantly from 12 ± 4.9 mmHg to 4.3 ± 1.9 mmHg postoperatively (P < .001). The mean MR grade decreased from 3.73 ± 0.45 to 0.96 ± 1.08 postoperatively (P < .001).
Conclusion: We conclude that repair is possible in patients with rheumatic mitral valve dysfunction. Current techniques with some modifications can be efficient to restore both the anatomy and physiology (better function) of the mitral valve and can lead to favorable early and midterm outcomes. We, therefore, recommend that the number of rheumatic mitral repair procedures should be increased in developing countries to achieve the best results.
- Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 2004;923:1–122, back cover.
- Enriquez-Sarano M, Schaff HV, Orszulak TA, et al. 1995. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis, Circ 91:1022 -1028.
- Duran CG, Revuelta JM, Gaite L, et al. 1988. Stability of mitral reconstructive surgery at 10–12 years for predominantly rheumatic valvular disease, Circ 783 :2, I91-96.
- Erez E, Kanter KR, Isom E, et al. 2003. Mitral valve replacement in children, J Heart Valve Dis 12: 25-29.
- Duran CM, Gometza B, De Vol EB. 1991. Valve repair in rheumatic mitral disease, Circ 845: III125-132.
- AM Gillinov, DM Cosgrove, EH Blackstone, et al. 1998. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 116: 734-743.
- TE David, A Omran, S Armstrong, et al. 1998. Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg 115: 1279-1285.
- TE David, S Armstrong, Z Sun, et al. 1993. Results of mitral valve repair for mitral regurgitation due to degenerative disease. Ann Thorac Surg 56: 7-12.
- EA Grossi, AC Galloway, JS Miller, et al. 1998. Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated? J Thorac Cardiovasc Surg 115: 389-394.
- Duran, BH Gometza, E Saad, et al. 1994. Valve repair in rheumatic mitral disease: an unsolved problem. J Cardiol Surg 9: 282-285.
- Espada R, Westaby S. 1998. New developments in mitral valve repair. Curr Opin Cardiol 13(2):80-4.
- Bakir I, Onan B, Selen Onan I, et al. 2013. Is Rheumatic Mitral Valve Repair Still a Feasible Alternative? Indications, Technique, and Results. Tex Heart Inst J 40(2): 163–169.
- Pomerantzeff PMA, Brandão CMA, Faber CN, et al. 1999. Plástica da valva mitral: resultados aos 17 anos de experiência. Rev Bras Cir Cardiovasc 14(3):185-90.
- David TE. 1997. The appropriateness of mitral valve repair for rheumatic mitral valve disease. J Heart Valve Dis 6(4):373-4.
- Suri RM, Schaff HV, Dearani JA, et al. 2006. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg 82(3):819–26.
- Chauvaud S, Fuzellier JF, Berrebi A, et al. 2001. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circ 104(12 Suppl 1): I12–5.
- Shuhaiber J, Anderson RJ. 2007. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg 31(2):267-75.
- Pomerantzeff PMA, Brandão CMA, Faber CM, et al. 1998. Plástica da valva mitral em portadores de febre reumática. Rev Bras Cir Cardiovasc 13(3):211-5.
- Wang YC, Tsai FC, Chu JJ, et al. 2008. Midterm outcomes of rheumatic repair versus replacement. Int Heart J 49(5):565-76.
- Kumar AS, Talwar S, Saxena A, et al. 2006. Results of mitral valve repair in rheumatic mitral regurgitation. Interact Cardiovasc Thorac Surg 5(4):356-61.
- Yau TM, El-Ghoneimi YA, Armstrong S, et al. 2000. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg 119(1):53–60.
- Antunes MJ, Magalhaes MP, Colsen PR, et al. 1987. Valvuloplasty for rheumatic mitral valve disease. A surgical challenge. J Thorac Cardiovasc Surg 94(1):44–56.
- Silberman S, Klutstein MW, Sabag T, et al. 2009. Repair of ischemic mitral regurgitation: comparison between flexible and rigid annuloplasty rings. Ann Thorac Surg 87(6):1721–7.
- Bernal JM, Ponton A, Diaz B, et al. 2010. Combined mitral and tricuspid valve repair in rheumatic valve disease: fewer reoperations with prosthetic ring annuloplasty. Circ 121(17):1934–40.
- David TE, Komeda M, Pollick C, et al. 1989. Mitral valve annuloplasty: the effect of the type on left ventricular function. Ann Thorac Surg 47(4):524–8.
- Okada Y, Shomura T, Yamamura Y, et al. 1995. Comparison of the Carpentier and Duran prosthetic rings used in mitral reconstruction. Ann Thorac Surg 59(3):658–63.
- David TE, Omran A, Armstrong S, et al. 1998. Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg 115(6):1279–86.
- Kobayashi J, Sasako Y, Bando K, et al. 2000. Ten-year experience of chordal replacement with expanded polytetrafluoroethylene in mitral valve repair. Circ 102(19 Suppl 3): III30–4.
- Gupta A, Gharde P, Kumar AS. 2010. Anterior mitral leaflet length: predictor for mitral valve repair in a rheumatic population. Ann Thorac Surg 90(6):1930–3.
- Acar C, de Ibarra JS, Lansac E. 2004. Anterior leaflet augmentation with autologous pericardium for mitral repair in rheumatic valve insufficiency. J Heart Valve Dis 13(5):741–6.
- Kim JB, Kim HJ, Moon DH, et al. 2010. Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement. Eur J Cardiothorac Surg 37(5):1039-46.
- Petrucci Jr O, Oliveira PPM, Silveira LM, et al. 1999. Resultados a médio prazo de anuloplastia com órtese maleável de pericárdio bovino na insuficiência mitral reumática. Rev Bras Cir Cardiovasc 14(2):105-8.
- Antunes MJ, Magalhães MP, Colsen PR, et al. 1987. Valvuloplasty for rheumatic mitral valve disease. A surgical challenge. J Thorac Cardiovasc Surg 94(1):44-56.
- Brandão CMA, Guedes MAV, Silva MF, et al. 2007. Plástica da valva mitral com a técnica do "duplo teflon": resultados de 10 anos. Rev Bras Cir Cardiovasc 22(4):448-53.
- Fernandez J, Joyce DH, Hirschfeld K, et al. 1992. Factors affecting mitral valve reoperation in 317 survivors after mitral valve reconstruction. Ann Thorac Surg 54(3):440-7.
- Chauvaud S, Perier P, Touati G, et al. 1986. Long-term results of valve repair in children with acquired mitral valve incompetence. Circ 74(3 Pt 2):I104-9.
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).